Navigation Links
Phase III trial of dapivirine ring begins in Africa: New HIV prevention approach for women
Date:7/24/2012

randomly assigned to use either the dapivirine ring or a placebo ring that looks the same but contains no active drug. Participants will be instructed how to insert and remove the ring, which they will replace every four weeks over the course of the one to two years they are in the study. All participants will receive ongoing HIV risk reduction counseling, condoms and diagnosis and treatment of sexually transmitted infections (STIs).

The results of ASPIRE, which are expected late 2014 or early 2015, together with results of The Ring Study, as well as smaller, supporting studies, will form the basis of an application that IPM plans to submit to regulatory authorities seeking approval of the dapivirine ring for widespread use.

"Through IPM's partnership with MTN and NIH, we are able to conduct two pivotal studies in parallel and get the answers we need quickly," said Zeda Rosenberg, Sc.D., chief executive officer of IPM, a nonprofit product development partnership based in Silver Spring, Md. "Regulators usually require results of two large-scale Phase III trials, along with data from other supporting studies, to approve a product for use. This unique collaboration aims to help us make dapivirine ring available as quickly as possible to women in developing countries if it is proven effective and safe for long-term use."

Of the more than 34 million people living with HIV, half are women; and women account for 59 percent of adults with HIV in sub-Saharan Africa, where unprotected heterosexual intercourse is the primary driver of the epidemic. Young women are especially vulnerable; women ages 15 to 24 are up to five times more likely to become infected with HIV than young men. Efforts to promote abstinence, monogamy and the use of male condoms have not been enough to stop the HIV epidemic nor are these practical methods in many settings.

IPM is developing dapivirine for use as a microbicide through a royalty-free licensing agreement w
'/>"/>

Contact: Lisa Rossi
rossil@upmc.edu
412-916-3315
Microbicide Trials Network
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. ALS patients differ on treatment choices in later phases of disease
2. Reach2HD, a Phase II study in Huntingtons disease, launched
3. Analysis of KRYSTEXXA phase III data demonstrates improved health-related quality of life and physical function in refractory chronic gout patients
4. Brain Tumor Vaccine Shows Promise in Early Trial
5. URMC clinical trial tests new regimen for hypertension
6. Analysis Finds Clinical Trials Often Small, of Poor Quality
7. US spends far more for health care than 12 industrialized nations, but quality varies
8. New Weight-Loss Drug Shows Promise in Trial
9. Palpitations are predictive of future atrial fibrillation
10. Trial Set to See if Drug Can Prevent Alzheimers
11. Experts call for clinical trials to test non-skeletal benefits of vitamin D
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... July 30, 2015 , ... According ... do not find a complete removable denture acceptable. The demand for dental implants ... that incorporate less expensive, immediate loading techniques will have the ability to offer ...
(Date:7/30/2015)... ... ... many people place a lot of focus on the different types of food that need to ... key component to successful weight gain is knowing when to eat so that the ... gives three tips on when to eat to gain weight. , The first thing to ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... PeopleKeys, a ... air a “Managing Stress: Train the Trainer” webinar. The webinar, the newest installment in ... August 13th, 2015. , The Managing Stress: Train the Trainer webinar is intended for ...
(Date:7/29/2015)... ... July 30, 2015 , ... Macro Wealth Management (MWM) ... the Smile for a Lifetime program by encouraging their clients to donate their MWM ... MWM Presidents Dr. Mart McClellan and Tim Streid, who see charitable giving as an ...
(Date:7/29/2015)... Plano, TX (PRWEB) , ... July 30, 2015 ... ... best content available for their clients, BOC approved provider of online continuing ... six new course offerings to their exclusive Andrews Research and Education Sports Medicine ...
Breaking Medicine News(10 mins):Health News:Chicago Implant Dentist/Implantologist Dr. Irfan Atcha Speaks to Local Dentists about Advances in Dental Implants in August. 2Health News:Chicago Implant Dentist/Implantologist Dr. Irfan Atcha Speaks to Local Dentists about Advances in Dental Implants in August. 3Health News:CB-1 Weight Gainer Gives Three Tips on When to Eat to Gain Weight 2Health News:CB-1 Weight Gainer Gives Three Tips on When to Eat to Gain Weight 3Health News:PeopleKeys to Air “Managing Stress: Train the Trainer” DISC Webinar 2Health News:Smile for a Lifetime (S4L) Partners with Macro Wealth Management (MWM) Helping More Children Get Braces 2Health News:Elite Online Continuing Education Provider Adds Six New Athletic Training Courses to Exclusive Andrews Research and Education Sports Medicine Series 2Health News:Elite Online Continuing Education Provider Adds Six New Athletic Training Courses to Exclusive Andrews Research and Education Sports Medicine Series 3
... physical exercise has been shown to trigger migraine headaches among ... well tolerated by patients. The findings show that the program ... The study is published in Headache: The Journal of ... sample of migraine sufferers who were examined before, during and ...
... 26 Results of a Mayo Clinic study ... predictive" of a major cardiac event, such as a heart ... or moderate risk, according to researchers.The study will be presented ... American College of Cardiology Annual Scientific Session in ...
... 26 While it is touted as a major tool ... has serious implications for Americans, health privacy. The Institute ... (H.R. 1, Public Law No. 111-5) weakens individuals, control over ... stimulus law plans for every American to use an electronic ...
... Mylan Inc. (Nasdaq: MYL ) today ... Matrix Laboratories Limited from minority shareholders pursuant to a ... owns approximately 71.2% of Matrix and controls more than ... transaction is anticipated to be accretive to Mylan,s 2009 ...
... stronger than current imaging, researchers say , , THURSDAY, March ... resonance imaging (MRI) can better detect molecular changes inside ... cancer, say Duke University chemists. , MRI uses hydrogen ... magnetic pulses and radio waves, but the process requires ...
... Transdermal delivery of estrogen therapy available by prescription ... (VTE), or blood clotting, in postmenopausal patients when compared ... study was conducted by researchers at NYU Langone Medical ... Menopause : The Journal of the North ...
Cached Medicine News:Health News:Mayo Study Shows Simple Finger Device May Help Predict Future Heart Events, Such as Heart Attack 2Health News:Mayo Study Shows Simple Finger Device May Help Predict Future Heart Events, Such as Heart Attack 3Health News:Economic Stimulus Law Weakens Americans' Control Over Personal Health Information 2Health News:Mylan Announces Intention to Purchase Remaining Interest in Matrix Laboratories and Delist Matrix from Indian Stock Exchanges 2Health News:Mylan Announces Intention to Purchase Remaining Interest in Matrix Laboratories and Delist Matrix from Indian Stock Exchanges 3Health News:New study suggests Rx estrogen delivery through the skin may show safety benefits as opposed to oral delivery 2
(Date:7/30/2015)...  IDEXX Laboratories, Inc. (NASDAQ: IDXX ) today ... $413 million, an increase of 6% compared to the ... US dollar reduced reported revenue growth by 7%. Normalized ... 11%, supported by strong growth in the Companion Animal ... was $0.60 for the quarter, an increase of 9% ...
(Date:7/29/2015)... Mass. , July 29, 2015 Insulet Corporation ... pump technology with its OmniPod ® Insulin Management ... months ended June 30, 2015. The Company also announced ... second quarter financial results and conference call from Thursday, ... Preliminary Second Quarter Revenue Highlights: ...
(Date:7/29/2015)... PARSIPPANY, N.J. and BERKELEY, Calif. ... Inc. and Plexxikon Inc., a member of the Daiichi ... Journal of Medicine (NEJM) published clinical trial results ... CSF-1R inhibitor, induced prolonged tumor regressions in most patients ... aggressive neoplasm of the joint or tendon sheath. ...
Breaking Medicine Technology:IDEXX Laboratories Announces Second Quarter Results 2IDEXX Laboratories Announces Second Quarter Results 3IDEXX Laboratories Announces Second Quarter Results 4IDEXX Laboratories Announces Second Quarter Results 5IDEXX Laboratories Announces Second Quarter Results 6IDEXX Laboratories Announces Second Quarter Results 7IDEXX Laboratories Announces Second Quarter Results 8IDEXX Laboratories Announces Second Quarter Results 9IDEXX Laboratories Announces Second Quarter Results 10IDEXX Laboratories Announces Second Quarter Results 11IDEXX Laboratories Announces Second Quarter Results 12IDEXX Laboratories Announces Second Quarter Results 13IDEXX Laboratories Announces Second Quarter Results 14IDEXX Laboratories Announces Second Quarter Results 15IDEXX Laboratories Announces Second Quarter Results 16IDEXX Laboratories Announces Second Quarter Results 17IDEXX Laboratories Announces Second Quarter Results 18IDEXX Laboratories Announces Second Quarter Results 19IDEXX Laboratories Announces Second Quarter Results 20IDEXX Laboratories Announces Second Quarter Results 21IDEXX Laboratories Announces Second Quarter Results 22IDEXX Laboratories Announces Second Quarter Results 23IDEXX Laboratories Announces Second Quarter Results 24IDEXX Laboratories Announces Second Quarter Results 25IDEXX Laboratories Announces Second Quarter Results 26IDEXX Laboratories Announces Second Quarter Results 27IDEXX Laboratories Announces Second Quarter Results 28IDEXX Laboratories Announces Second Quarter Results 29Insulet Reports Preliminary Second Quarter 2015 Revenue Results 2Insulet Reports Preliminary Second Quarter 2015 Revenue Results 3Insulet Reports Preliminary Second Quarter 2015 Revenue Results 4Insulet Reports Preliminary Second Quarter 2015 Revenue Results 5Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients 2Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients 3Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients 4
... Alere Inc. (NYSE: ALR ), a global ... home through the merger of rapid diagnostics and health management, today ... B Convertible Perpetual Preferred Stock (NYSE: ALR.PR.B).  The dividend is payable ... stock at the close of business on April 2, 2012.  ...
... Pharmaceuticals, Inc. (NASDAQ: IDIX ), a biopharmaceutical ... for the treatment of human viral diseases, today announced ... member and Lead Director of Idenix,s Board and former ... serve as Chairman of the Board. Additionally, Idenix has ...
Cached Medicine Technology:Idenix Pharmaceuticals Elects Thomas Hodgson as Chairman of the Board and Appoints Michael Wyzga to Its Board of Directors 2
The 3.0 mm Cannulated Screw can be used with or without threaded washer. Uses 1.1 mm threaded or non-threaded guide wire. , ,The Threaded Washer provides a recessed internal buttress which allows the...
... BIAX Total Wrist System was the first wrist ... normal wrist. Since then it has become the ... , ,During total wrist replacement surgery, doctors remove ... joint replacement implant in place of the damaged ...
... a simple, effective instrument to grasp soft tissue ... and loop. The grasping function of the instrument ... and precisely place a stitch up to 1 ... all in one quick step. The sterile, single ...
... Punch Forceps provide superior tissue excision with ... an aggressive tooth pattern to capture loose ... a unique stress pin buffering system to ... use, the stress pin buffering system applies ...
Medicine Products: